Princeton Medical Institute is a nationally known Alzheimer’s Research Center and is the only NJ Alzheimer’s Center to be part of the Global Alzheimer’s Platform initiative. Dr. Jeffrey T. Apter, right, is medical director at Princeton Medical Institute, senior attending physician at University Medical Center of Princeton, and a member of the Scientific Advisory Board of the New Jersey Alzheimer Association. At various locations, he gives lectures on memory loss to the public and provide essential information on how to combat this condition. As Medical Director and Principle Investigator for Princeton Medical Institute Dr. Apter directs clinical trials in the areas of CNS and general medicine. With personal experience in over 350 trials in Depression, Anxiety, Bipolar Disorder and Alzheimer’s Disease, Dr. Apter fully understands the strict requirements associated with clinical research as well as the needs of his patients.
Fortunately, clinical researchers are now exploring the earliest phase of the illness, called mild cognitive impairment (MCI) due to Alzheimer’s disease. During this stage, patients have memory loss along with spinal fluid abnormalities and Amyloid PET scans confirming early Alzheimer’s disease.
Study volunteers may receive study-related medical care; study medication, laboratory testing, and cognitive testing. Medical insurance is not necessary to participate in these studies. If you are suffering from Memory Loss, or can benefit from a free initial consultation regarding your mental health, please call 609-921-6050 for a free initial consultation today. Caregivers and patients interested in participation in any of PMI’s cutting-edge studies are welcome to learn more at PMI’s website: www.PrincetonMedicalInstitute.com.